Intercept Pharmaceuticals, Inc.

Legal & General Group Plc

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

30,739

Value ($000)

570

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	570	0.0%	30,739	9/30/2023
2023 Q2	8/14/2023	322	0.0%	29,129	6/30/2023
2023 Q1	5/15/2023	223	0.0%	16,632	3/31/2023
2022 Q4	2/14/2023	155	0.0%	12,548	12/31/2022
2022 Q3	11/14/2022	142	0.0%	10,148	9/30/2022
2022 Q2	8/22/2022	131	0.0%	9,468	6/30/2022
2022 Q1	5/16/2022	176	0.0%	10,834	3/31/2022
2021 Q4	2/14/2022	176	0.0%	10,834	12/31/2021
2021 Q3	11/15/2021	165	0.0%	11,132	9/30/2021
2021 Q2	8/12/2021	305	0.0%	15,288	6/30/2021
2021 Q1	5/17/2021	345	0.0%	14,949	3/31/2021
2020 Q4	2/12/2021	370	0.0%	14,983	12/31/2020
2020 Q3	11/13/2020	622	0.0%	15,025	9/30/2020
2020 Q2	8/14/2020	774	0.0%	16,154	6/30/2020
2020 Q1	5/14/2020	882	0.0%	14,011	3/31/2020
2019 Q4	2/13/2020	1,886	0.0%	15,224	12/31/2019